The live broadcast will feature expert insights from the leading minds in oncology
OncLive®, the leading digital provider of resources and information to oncology professionals, will host a live webinar on the “Advances in First-Line Therapy for NSCLC” on Friday, October 5, at 1 p.m. (EDT).
“We look forward to presenting this webinar that will uncover a comprehensive guide to spearheading top issues in the non-small cell lung cancer (NSCLC) space,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of OncLive®. “Attendees will also gain cutting-edge insight from three leading lung cancer professionals to help their organization’s lung cancer practices.”
Presenters for the webinar include:
Designed for oncologists, physicians and health care professionals interested in learning about emerging therapies for NSCLC, the webinar will present a brief review of new data from the year’s most impactful lung cancer meeting and research in a single location. Attendees can also submit questions before and during the webinar.
For more information and to register, visit https://www.onclive.com/webinars/nsclc-webinar.
About OncLive®
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates, Inc., Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates, Inc., is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180911005776/en/
OncLive® Media:
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhassoc.com